Are Fees The New Rebates? PhRMA Highlights Shifts In PBM Practices As House Tees Up Reform Vote

Pharmacy benefit managers are increasingly making money off new types of fees tied to list prices, drug industry lobby says, highlighting importance of delinking all PBM compensation from the cost of medicines. Most Congressional proposals in play do not include delinkage provision.

stick shift
PBM profit sources have shifted, new PhRMA-commissioned report says. • Source: Shutterstock

More from Pricing Debate

More from Market Access